-
Share
547 Posts.
330
08/03/24
17:38
Share
Your holding in EX1 will be worth pennies in the coming waves of dilution, so it's not even worth thinking about.
So the question becomes, is the Tryp IPO worthwhile investing in?
I can't imagine how an IV infusion, even with purported benefits, could be successful over oral administration unfortunately. So the solution is DOA.
However. Psychedelics now are like cannabis in 2019, so there might be some good money to be made here amongst the coming pumpy pumps.